BLOG

Precisions Medicine

Harnessing AI Innovation to Modernize Clinical Trials

Similarly, PathAI is working on creating imaging biomarkers that can be used in clinical trials in cancer and liver diseases such as metabolic dysfunction-associated steatohepatitis (MASH).